INTRODUCTION: Imaging plays a crucial role in the diagnosis, prognosis and follow-up of traumatic brain injury. Whereas computed tomography plays a pivotal role in the acute setting, magnetic resonance imaging is best suited to detect the true extent of traumatic brain injury, and more specifically diffuse axonal injury. Post-traumatic brain atrophy is a well-known complication of traumatic brain injury. PURPOSE: This study investigated the correlation between diffuse axonal injury detected with fluid-attenuated inversion recovery and susceptibility-weighted imaging magnetic resonance imaging, post-traumatic brain atrophy and functional outcome (Glasgow outcome scale - extended). MATERIALS AND METHODS: Twenty patients with a closed head injury and diffuse axonal injury detected with fluid-attenuated inversion recovery and susceptibility-weighted imaging were included. The total volumes of the diffuse axonal injury fluid-attenuated inversion recovery lesions were determined for each subject's initial (<14 days) and follow-up magnetic resonance scan (average: day 303 ± 83 standard deviation). The different brain volumes were automatically quantified using a validated and both US Food and Drug Administration-cleared and CE-marked machine learning algorithm (icobrain). The number of susceptibility-weighted imaging lesions and functional outcome scores (Glasgow outcome scale - extended) were retrieved from the Collaborative European NeuroTrauma Effectiveness Research Traumatic Brain Injury dataset. RESULTS: The volumetric fluid-attenuated inversion recovery diffuse axonal injury lesion load showed a significant inverse correlation with functional outcome (Glasgow outcome scale - extended) (r = -0.57; P = 0.0094) and white matter volume change (r = -0.50; P = 0.027). In addition, white matter volume change correlated significantly with the Glasgow outcome scale - extended score (P = 0.0072; r = 0.58). Moreover, there was a strong inverse correlation between longitudinal fluid-attenuated inversion recovery lesion volume change and whole brain volume change (r = -0.63; P = 0.0028). No significant correlation existed between the number of diffuse axonal injury susceptibility-weighted imaging lesions, brain atrophy and functional outcome. CONCLUSIONS: Volumetric analysis of diffuse axonal injury on fluid-attenuated inversion recovery imaging and automated brain atrophy calculation are potentially useful tools in the clinical management and follow-up of traumatic brain injury patients with diffuse axonal injury.
INTRODUCTION: Imaging plays a crucial role in the diagnosis, prognosis and follow-up of traumatic brain injury. Whereas computed tomography plays a pivotal role in the acute setting, magnetic resonance imaging is best suited to detect the true extent of traumatic brain injury, and more specifically diffuse axonal injury. Post-traumatic brain atrophy is a well-known complication of traumatic brain injury. PURPOSE: This study investigated the correlation between diffuse axonal injury detected with fluid-attenuated inversion recovery and susceptibility-weighted imaging magnetic resonance imaging, post-traumatic brain atrophy and functional outcome (Glasgow outcome scale - extended). MATERIALS AND METHODS: Twenty patients with a closed head injury and diffuse axonal injury detected with fluid-attenuated inversion recovery and susceptibility-weighted imaging were included. The total volumes of the diffuse axonal injury fluid-attenuated inversion recovery lesions were determined for each subject's initial (<14 days) and follow-up magnetic resonance scan (average: day 303 ± 83 standard deviation). The different brain volumes were automatically quantified using a validated and both US Food and Drug Administration-cleared and CE-marked machine learning algorithm (icobrain). The number of susceptibility-weighted imaging lesions and functional outcome scores (Glasgow outcome scale - extended) were retrieved from the Collaborative European NeuroTrauma Effectiveness Research Traumatic Brain Injury dataset. RESULTS: The volumetric fluid-attenuated inversion recovery diffuse axonal injury lesion load showed a significant inverse correlation with functional outcome (Glasgow outcome scale - extended) (r = -0.57; P = 0.0094) and white matter volume change (r = -0.50; P = 0.027). In addition, white matter volume change correlated significantly with the Glasgow outcome scale - extended score (P = 0.0072; r = 0.58). Moreover, there was a strong inverse correlation between longitudinal fluid-attenuated inversion recovery lesion volume change and whole brain volume change (r = -0.63; P = 0.0028). No significant correlation existed between the number of diffuse axonal injury susceptibility-weighted imaging lesions, brain atrophy and functional outcome. CONCLUSIONS: Volumetric analysis of diffuse axonal injury on fluid-attenuated inversion recovery imaging and automated brain atrophy calculation are potentially useful tools in the clinical management and follow-up of traumatic brain injury patients with diffuse axonal injury.
Authors: Anne M Hudak; R Ruth Caesar; Alan B Frol; Kim Krueger; Caryn R Harper; Nancy R Temkin; Sureyya S Dikmen; Mary Carlile; Christopher Madden; Ramon Diaz-Arrastia Journal: J Neurotrauma Date: 2005-11 Impact factor: 5.269
Authors: D D Blatter; E D Bigler; S D Gale; S C Johnson; C V Anderson; B M Burnett; D Ryser; S E Macnamara; B J Bailey Journal: AJNR Am J Neuroradiol Date: 1997-01 Impact factor: 3.825
Authors: A Pierallini; P Pantano; L M Fantozzi; M Bonamini; R Vichi; R Zylberman; F Pisarri; C Colonnese; L Bozzao Journal: Neuroradiology Date: 2000-12 Impact factor: 2.804
Authors: Andrew I R Maas; David K Menon; Ewout W Steyerberg; Giuseppe Citerio; Fiona Lecky; Geoffrey T Manley; Sean Hill; Valerie Legrand; Annina Sorgner Journal: Neurosurgery Date: 2015-01 Impact factor: 4.654
Authors: Miriam H Beauchamp; Richard Beare; Michael Ditchfield; Lee Coleman; Franz E Babl; Michael Kean; Louise Crossley; Cathy Catroppa; Keith O Yeates; Vicki Anderson Journal: Cortex Date: 2012-09-03 Impact factor: 4.027
Authors: Ellis Niemantsverdriet; Annemie Ribbens; Christine Bastin; Florence Benoit; Bruno Bergmans; Jean-Christophe Bier; Roxanne Bladt; Lene Claes; Peter Paul De Deyn; Olivier Deryck; Bernard Hanseeuw; Adrian Ivanoiu; Jean-Claude Lemper; Eric Mormont; Gaëtane Picard; Eric Salmon; Kurt Segers; Anne Sieben; Dirk Smeets; Hanne Struyfs; Evert Thiery; Jos Tournoy; Eric Triau; Anne-Marie Vanbinst; Jan Versijpt; Maria Bjerke; Sebastiaan Engelborghs Journal: J Alzheimers Dis Date: 2018 Impact factor: 4.472